China Healthcare
GenoMed CEO Invited to Speak at World DNA Day in China
By GenoMed, Inc.
Apr 29, 2005, 20:08

GenoMed Inc. ("the Company" or "GenoMed") (National Quotation Bureau's Pink Sheets Symbol GMED) announced today that its CEO, David Moskowitz MD, was invited to speak yesterday at World DNA and Genome Day in Dalian, China (www.dnaday.com) on "Genomics and Cardiovascular Disease."

Said Dr. Moskowitz, "It's an extraordinary honor to be invited to such a prestigious gathering of Nobel prize-winners and other scientific luminaries. Genomics is fulfilling the hope that thousands of physician-scientists have entertained for several thousand years: to find the source of human diseases so we can stop them. It's like finding the headwaters of a river in order to dam it."

Dr. Moskowitz continued, "Overactivity of angiotensin I-converting enzyme, known as 'ACE,' seems to be the cause of most diseases of aging, including cardiovascular disease and cancer, the two main causes of death in the U.S. Inhibitors of ACE have been used for over 25 years, although not in the doses pioneered by GenoMed. Actual patient outcomes over the next decade or two will prove whether we've found the Fountain of Youth or not. This hypothesis comes at a good time for Baby Boomers like me."

All rights reserved by www.rxpgnews.com